相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Using the Incremental Net Benefit Framework for Quantitative Benefit-Risk Analysis in Regulatory Decision-Making-A Case Study of Alosetron in Irritable Bowel Syndrome
Larry D. Lynd et al.
VALUE IN HEALTH (2010)
A Review of Quantitative Risk-Benefit Methodologies for Assessing Drug Safety and Efficacy-Report of the ISPOR Risk-Benefit Management Working Group
Jeff J. Guo et al.
VALUE IN HEALTH (2010)
Measuring Benefit and Balancing Risk: Strategies for the Benefit-Risk Assessment of New Medicines in a Risk-Averse Environment
S. Walker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Multiple sclerosis patients' benefit-risk preferences: Serious adverse event risks versus treatment efficacy
F. Reed Johnson et al.
JOURNAL OF NEUROLOGY (2009)
A Multiattribute Model for Evaluating the Benefit-Risk Profiles of Treatment Alternatives
James C. Felli et al.
MEDICAL DECISION MAKING (2009)
Safe Drugs and the Cost of Good Intentions
Hans-Georg Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A quantitative approach to benefit-risk assessment of medicines-part 1: The development of a new model using multi-criteria decision analysis
Filip Mussen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis
Louis P. Garrison et al.
HEALTH AFFAIRS (2007)
Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis
LD Lynd et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
分享论文
